Nanothermtx
1 known investors
Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.
Founders & leadership
AJ
Andreas JordanCEO & Founder
JL
Jan-Marc LieskovskyCBO
GS
Gernot SklenofskyCFO
Investors · 1
Competitors · 5
by search overlapBioworld7 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Integrated Nanotherapeutics Inc.6 shared keywordsIntegrated Nanotherapeutics (INT) is a preclinical-stage biotech developing antigen-specific immune tolerance therapies using lipid nanoparticles to treat autoimmune diseases such as Type 1 Diabetes, Multiple Sclerosis, and allergy. Its lead program, INT-101, targets Type 1 Diabetes, and the company also offers an LNP-based drug delivery platform for small molecules and nucleic acids.
Nanobiotix5 shared keywordsNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
Nanoscope Therapeutics4 shared keywordsNanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
Nanobots Therapeutics4 shared keywordsNanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
Companies competing with Nanothermtx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nanothermtx do?
- Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.
- Who founded Nanothermtx?
- Nanothermtx was founded by Andreas Jordan.
- Who are Nanothermtx's investors?
- Nanothermtx's investors include The Innovation Space.